Journal ArticleOPEN ACCESS

An ACE therapy for COVID-19

  • Rodell C
Science Translational Medicine (2020) 12(541)
DOI: 10.1126/scitranslmed.abb5676
N/ACitations
Citations of this article
31Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Recombinant human soluble ACE2 inhibits SARS-CoV-2 viral infection in human organoids in vitro.Recombinant human soluble ACE2 inhibits SARS-CoV-2 viral infection in human organoids in vitro.

Cite

CITATION STYLE

APA

Rodell, C. B. (2020). An ACE therapy for COVID-19. Science Translational Medicine, 12(541). https://doi.org/10.1126/scitranslmed.abb5676

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free